1-4 of 4
James P Roy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development and Optimisation of a CLEC12A-Targeting Inhibitory CAR to Improve the Safety Profile of SEMA4A CAR-T Cells in Multiple Myeloma

James P. Roy, Ee June Chua, Georgina S.F. Anderson, Ben Uttenthal, Michael A. Chapman
Journal: Blood
Blood (2024) 144 (Supplement 1): 1891.
https://doi.org/10.1182/blood-2024-211206
Published: 2024
Journal Articles

And-Gate CAR T-Cells to Improve Tumour Specificity and Targeting of Low-Expression Antigens in Multiple Myeloma

Georgina S.F. Anderson, Ieuan Walker, James P Roy, Michael A. Chapman
Journal: Blood
Blood (2023) 142 (Supplement 1): 751.
https://doi.org/10.1182/blood-2023-187418
Published: 2023
Journal Articles

Development of the First SEMA4A CAR-T Cell Targeting Multiple Myeloma

James P Roy, Georgina S.F. Anderson, Ieuan Walker, Michael A Chapman
Journal: Blood
Blood (2022) 140 (Supplement 1): 9961–9962.
https://doi.org/10.1182/blood-2022-168968
Published: 2022
Journal Articles

Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma

Georgina S.F. Anderson, Jose Ballester-Beltran, George Giotopoulos, Jose A. Guerrero, Sylvanie Surget, James C. Williamson, Tsz So, David Bloxham, Anna Aubareda, Ryan Asby, Ieuan Walker, Lesley Jenkinson, Elizabeth J. Soilleux, James P. Roy, Ana Teodósio, Catherine Ficken, Leah Officer-Jones, Sara Nasser, Sheri Skerget, Jonathan J. Keats, Peter Greaves, Yu-Tzu Tai, Kenneth C. Anderson, Marion MacFarlane, James E. Thaventhiran, Brian J.P. Huntly, Paul J. Lehner, Michael A. Chapman
Journal: Blood
Blood (2022) 139 (16): 2471–2482.
https://doi.org/10.1182/blood.2021015161
Published: 2022
Includes: Supplemental data